Stocks · News reference
8-K filing — aTYR PHARMA INC (ATYR)
Filed: 2026-08-07 AccNo: 0001339970-26-000051 Size: 411 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 7, 2026, 8:04 PM
- Checked
- Aug 7, 2026, 8:04 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
aTyr Pharma CFO Jill Broadfoot To Step Down As Of September 30; To Be Succeeded By Brandon Yaras As Of October 1
aTyr Pharma, Inc. (NASDAQ:ATYR) ("aTyr" or the "Company"), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase
Read original at benzingaaTyr Pharma CFO Jill Broadfoot To Step Down Sept. 30, 2026
Read original at benzingaaTyr Pharma Reduces Workforce By ~60%
Read original at benzinga